These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15337242)

  • 21. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
    J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
    Hall JM; McDonnell DP
    Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB; Polikarpov I; Andricopulo AD
    J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies.
    Kinzel O; Fattori D; Muraglia E; Gallinari P; Nardi MC; Paolini C; Roscilli G; Toniatti C; Gonzalez Paz O; Laufer R; Lahm A; Tramontano A; Cortese R; De Francesco R; Ciliberto G; Koch U
    J Med Chem; 2006 Sep; 49(18):5404-7. PubMed ID: 16942012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.
    Chesworth R; Zawistoski MP; Lefker BA; Cameron KO; Day RF; Mangano FM; Rosati RL; Colella S; Petersen DN; Brault A; Lu B; Pan LC; Perry P; Ng O; Castleberry TA; Owen TA; Brown TA; Thompson DD; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2729-33. PubMed ID: 15125923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.
    McDonnell DP; Wijayaratne A; Chang CY; Norris JD
    Am J Cardiol; 2002 Jul; 90(1A):35F-43F. PubMed ID: 12106639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
    Girault I; Bièche I; Lidereau R
    Maturitas; 2006 Jul; 54(4):342-51. PubMed ID: 16822624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the science of estrogen receptor modulation.
    Meegan MJ; Lloyd DG
    Curr Med Chem; 2003 Feb; 10(3):181-210. PubMed ID: 12570707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossroads of estrogen receptor and NF-kappaB signaling.
    Biswas DK; Singh S; Shi Q; Pardee AB; Iglehart JD
    Sci STKE; 2005 Jun; 2005(288):pe27. PubMed ID: 15956359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis.
    Hess-Wilson JK; Boldison J; Weaver KE; Knudsen KE
    Breast Cancer Res Treat; 2006 Apr; 96(3):279-92. PubMed ID: 16328721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a yeast estrogen screen in non-biomarker species Varicorhinus barbatulus fish with two estrogen receptor subtypes to assess xenoestrogens.
    Fu KY; Chen CY; Chang WM
    Toxicol In Vitro; 2007 Jun; 21(4):604-12. PubMed ID: 17258427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J; Li W; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
    Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
    Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
    Lonard DM; Smith CL
    Steroids; 2002 Jan; 67(1):15-24. PubMed ID: 11728517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light-activated transcription and repression by using photocaged SERMs.
    Shi Y; Koh JT
    Chembiochem; 2004 Jun; 5(6):788-96. PubMed ID: 15174161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
    Blizzard TA; DiNinno F; Morgan JD; Wu JY; Chen HY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3865-8. PubMed ID: 15225686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural explanation for ERalpha/ERbeta SERM discrimination.
    Greene GL; Shiau AK; Nettles KW
    Ernst Schering Res Found Workshop; 2004; (46):33-45. PubMed ID: 15248503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.